A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy Results
Durvalumab (MEDI4736) 联合碳离子放射疗法和每周顺铂治疗局部晚期宫颈癌患者的 Ib 期研究(DECISION 研究):早期安全性和有效性结果
期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms241310565
Okonogi, Noriyuki; Murata, Kazutoshi; Yamada, Shigeru; Habu, Yuji; Hori, Makoto; Kurokawa, Tomoya; Inaba, Yosuke; Fujiwara, Tadami; Fujii, Yasuhisa; Hanawa, Michiko; Kawasaki, Yohei; Hattori, Yoko; Suzuki, Kazuko; Tsuyuki, Kyoko; Wakatsuki, Masaru; Koto, Masashi; Hasegawa, Sumitaka; Ishikawa, Hitoshi; Hanaoka, Hideki; Shozu, Makio; Tsuji, Hiroshi; Usui, Hirokazu